BRIEF—Collaboration to test 'Onco-Mimics' potential

French microbiome specialist Enterome has entered into a collaboration with the Memorial Sloan Kettering Cancer Center (MSK) to evaluate the potential of gut microbiome-derived antigens.

The collaboration with MSK aims to generate further evidence to support Enterome’s “Onco-Mimics” platform, and will look at validating its application in several tumor types.

The firm is looking to develop its lead candidate, EO2401, as a potential new immunotherapy for several indications, with an initial focus on recurrent glioblastoma multiforme (GBM).